vasculartx.comHealthcareFounded: 2001Funding to Date: $74.51MM
Vascular Therapies is a late-stage biopharmaceutical company focused on developing the Sirolimus-eluting collagen implant for local, perivascular drug delivery.
View Enterprise Value for Vascular Therapies.